Related Experiment Video
Updated: Jun 15, 2026
08:04
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Is LGI2 the candidate gene for partial epilepsy with pericentral spikes?
Vachiranee Limviphuvadh1, Ling Ling Chua, Frank Eisenhaber
1Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, Singapore 138671, Singapore. vachiraneel@bii.a-star.edu.sg
Journal of Bioinformatics and Computational Biology
|February 26, 2010
Summary
Researchers identified LGI2 as a strong candidate gene for partial epilepsy with pericentral spikes (PEPS). This finding could lead to genetic diagnosis and better understanding of PEPS disease mechanisms.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Partial epilepsy with pericentral spikes (PEPS) is a familial epilepsy.
- The disease locus is mapped to chromosome 4p15, but the causative gene remains unknown.
Purpose of the Study:
- To identify the causative gene for PEPS.
- To investigate LGI2 as a prime candidate gene for PEPS.
- To explore potential links between PEPS and similar phenotypes in reported patients.
Main Methods:
- Protein sequence analysis.
- Analysis of patient-specific chromosomal deletions.
- Literature review of related LGI proteins and epilepsy mechanisms.
Main Results:
- LGI2 is proposed as the prime candidate gene for PEPS based on sequence analysis and chromosomal deletions.
- Two patient reports with similar phenotypes and deletions in the PEPS locus may represent the same disease.
Conclusions:
- Screening PEPS patients and those with similar phenotypes for LGI2 mutations is recommended.
- Establishing the linkage between PEPS and LGI2 will enable genetic diagnosis and hereditary studies.
- Understanding LGI2's molecular mechanisms can inform therapeutic strategies for PEPS.
More Related Videos
Related Concept Videos
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:19Seizures ll: Types
Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...